This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Michael Galluppi: Innovator in Dry Powder Inhalers
Introduction
Michael Galluppi is a notable inventor based in Middlesex, NJ (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on dry powder inhalers. His expertise and inventions have the potential to enhance the efficacy of drug administration for patients.
Latest Patents
Michael Galluppi holds a patent related to drug products, dry powder inhalers, and polyflux collider arrangements. This patent focuses on the development of dry powder inhalers and drug products, specifically addressing the use of polyflux colliders for de-agglomerating dry powder in dispensers. The invention provides various embodiments that utilize colliding streams of dry powder to achieve desirable de-agglomerating capabilities, thereby improving the performance of dry powder dispensers.
Career Highlights
Michael Galluppi is associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His work at Merck has allowed him to contribute to advancements in drug delivery technologies. With a patent portfolio that includes 1 patent, he has established himself as a key player in the field of inhalation therapies.
Collaborations
Michael has collaborated with notable colleagues such as Scott Robert Brown and Peter A Basile. These collaborations have likely fostered an environment of innovation and creativity, leading to the development of cutting-edge solutions in the pharmaceutical industry.
Conclusion
In summary, Michael Galluppi is an accomplished inventor whose work on dry powder inhalers and drug products has the potential to significantly impact patient care. His contributions to the field exemplify the importance of innovation in healthcare.